IIL setting up animal vax facility in Genome Valley

10 months ago 10

HYDERABAD: Biotech player Indian Immunologicals Limited (IIL) is setting up a greenfield veterinary vaccines manufacturing facility in

Genome Valley

, Hyderabad, at an investment of 700 crore.
The new facility, which will create over 750 direct and indirect jobs, will manufacture Foot and Mouth Disease vaccine (

FMD-Vac

) as well as a combination Foot and Mouth Disease and Haemorrhagic Septicaemia vaccine (FMD+HS-Vac), the company said on Thursday.

The upcoming facility will have a capacity to produce 300 million doses per annum, with 150 million doses per annum each of the two vaccines.
IIL said the greenfield vaccine manufacturing facility will be equipped with a BSL-3 facility for manufacturing drug substances as well as a fill-finish capability for the production of drug products for the two animal vaccines.

The facility is coming up on a 14-acre plot in Phase III of the Telangana State Industrial Infrastructure Corporation Ltd's Biotech Park at Karkapatla in Siddipet district.
National Dairy Development Board and IIL chairman Meenesh Shah, who led the ground-breaking ceremony on Thursday, said, "IIL's ability to discover and manufacture affordable vaccines has saved the exchequer several thousand crores of rupees."

IIL managing director Dr K Anand Kumar, said the company is in an exponential growth phase and expected to grow 40% this year alone.
"In order to sustain the momentum, IIL is seriously considering making additional investments in building infrastructure within India and in other emerging geographies including Africa in a manner to develop tools that will help in control and eradication of diseases," Anand Kumar said.
The Hyderabad-headquartered IIL, which was set up by NDDB in 1982, is one of the largest vaccine manufacturers in Asia with multiple GMP manufacturing sites that produce human and animal vaccines that are exported to 50 countries.It has developed various types of vaccines ranging from inactivated and live viral vaccines to polysaccharide conjugate vaccines, recombinant subunit vaccines, toxoid vaccines, live bacterial vaccines.

Article From: timesofindia.indiatimes.com
Read Entire Article



Note:

We invite you to explore our website, engage with our content, and become part of our community. Thank you for trusting us as your go-to destination for news that matters.

Certain articles, images, or other media on this website may be sourced from external contributors, agencies, or organizations. In such cases, we make every effort to provide proper attribution, acknowledging the original source of the content.

If you believe that your copyrighted work has been used on our site in a way that constitutes copyright infringement, please contact us promptly. We are committed to addressing and rectifying any such instances

To remove this article:
Removal Request